Literature DB >> 30368414

Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC.

Ibiayi Dagogo-Jack1, Sara E Stevens1, Jessica J Lin1, Rebecca Nagy2, Lorin Ferris1, Alice T Shaw1, Justin F Gainor3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30368414     DOI： 10.1016/j.jtho.2018.06.021

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  19 in total

1.  Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804M Kinase.

Authors:  Rebecca Newton; Bohdan Waszkowycz; Chitra Seewooruthun; Daniel Burschowsky; Mark Richards; Samantha Hitchin; Habiba Begum; Amanda Watson; Eleanor French; Niall Hamilton; Stuart Jones; Li-Ying Lin; Ian Waddell; Aude Echalier; Richard Bayliss; Allan M Jordan; Donald Ogilvie
Journal:  ACS Med Chem Lett       Date:  2020-02-28       Impact factor: 4.345

2.  Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.

Authors:  Thereasa A Rich; Karen L Reckamp; Young Kwang Chae; Robert C Doebele; Wade T Iams; Michael Oh; Victoria M Raymond; Richard B Lanman; Jonathan W Riess; Thomas E Stinchcombe; Vivek Subbiah; David R Trevarthen; Stephen Fairclough; Jennifer Yen; Oliver Gautschi
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

Review 3.  Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers.

Authors:  Faraat Ali; Kumari Neha; Garima Chauhan
Journal:  Arch Pharm Res       Date:  2022-05-22       Impact factor: 4.946

Review 4.  Non-small-cell lung cancer: how to manage RET-positive disease.

Authors:  Elisa Andrini; Mirta Mosca; Linda Galvani; Francesca Sperandi; Biagio Ricciuti; Giulio Metro; Giuseppe Lamberti
Journal:  Drugs Context       Date:  2022-07-11

5.  RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.

Authors:  Benjamin J Solomon; Lavinia Tan; Jessica J Lin; Stephen Q Wong; Sebastian Hollizeck; Kevin Ebata; Brian B Tuch; Satoshi Yoda; Justin F Gainor; Lecia V Sequist; Geoffrey R Oxnard; Oliver Gautschi; Alexander Drilon; Vivek Subbiah; Christine Khoo; Edward Y Zhu; Michele Nguyen; Dahlia Henry; Kevin R Condroski; Gabrielle R Kolakowski; Eliana Gomez; Joshua Ballard; Andrew T Metcalf; James F Blake; Sarah-Jane Dawson; Wayne Blosser; Louis F Stancato; Barbara J Brandhuber; Steve Andrews; Bruce G Robinson; S Michael Rothenberg
Journal:  J Thorac Oncol       Date:  2020-01-24       Impact factor: 15.609

Review 6.  Decade in review: a new era for RET-rearranged lung cancers.

Authors:  Noura J Choudhury; Alexander Drilon
Journal:  Transl Lung Cancer Res       Date:  2020-12

7.  Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib.

Authors:  Simon S Terzyan; Tao Shen; Xuan Liu; Qingling Huang; Peng Teng; Mi Zhou; Frank Hilberg; Jianfeng Cai; Blaine H M Mooers; Jie Wu
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

8.  Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.

Authors:  J J Lin; S V Liu; C E McCoach; V W Zhu; A C Tan; S Yoda; J Peterson; A Do; K Prutisto-Chang; I Dagogo-Jack; L V Sequist; L J Wirth; J K Lennerz; A N Hata; M Mino-Kenudson; V Nardi; S-H I Ou; D S-W Tan; J F Gainor
Journal:  Ann Oncol       Date:  2020-09-29       Impact factor: 51.769

9.  [Chinese Expert Consensus on Next Generation Sequencing Diagnosis 
for Non-small Cell Lung Cancer (2020 Edition)].

Authors: 
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-09-20

10.  Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer.

Authors:  Lori J Wirth; Takashi Kohno; Hibiki Udagawa; Shingo Matsumoto; Genichiro Ishii; Kevin Ebata; Brian B Tuch; Edward Y Zhu; Michele Nguyen; Steve Smith; Lauren M Hanson; Michael R Burkard; LouAnn Cable; James F Blake; Kevin R Condroski; Barbara J Brandhuber; Steve Andrews; S Michael Rothenberg; Koichi Goto
Journal:  JCO Precis Oncol       Date:  2019-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.